No Data
No Data
Express News | Salarius Pharmaceuticals- Co's Relative Valuation Reduced to $2.31 Mln - SEC Filing
Salarius Pharmaceuticals | 10-Q: Q1 2025 Earnings Report
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to Its Scientific Advisory Board
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Salarius Pharmaceuticals Merger Partner Announces Series of Drug Candidates
Salarius Pharmaceuticals Advances Merger With Decoy Therapeutics to Enhance Development of Innovative Cancer and Viral Therapeutics
Den the Dragon : nice